Commentary: IL-17 in Chronic Inflammation: From Discovery to Targeting

Affiliations

Comment

Francesco Maione. Front Pharmacol. 2016.

. 2016 Aug 11:7:250.

doi: 10.3389/fphar.2016.00250. eCollection 2016.

No abstract available

Keywords: IL-17A; IL-17RA; autoimmune disease; cardiovascular disease; platelets.

Comment on

IL-17 in Chronic Inflammation: From Discovery to Targeting.
Beringer A, Noack M, Miossec P. Beringer A, et al. Trends Mol Med. 2016 Mar;22(3):230-241. doi: 10.1016/j.molmed.2016.01.001. Epub 2016 Jan 31. Trends Mol Med. 2016. PMID: 26837266 Review.

1. Alkaabi J. K., Ho M., Levison R., Pullar T., Belch J. J. (2003). Rheumatoid arthritis and macrovascular disease. Rheumatology 42, 292–297. 10.1093/rheumatology/keg083 - DOI - PubMed
1. Beringer A., Noack M., Miossec P. (2016). IL-17 in chronic inflammation: from discovery to targeting. Trends Mol. Med. 22, 230–241. 10.1016/j.molmed.2016.01.001 - DOI - PubMed
1. D'Acquisto F., Maione F., Pederzoli-Ribeil M. (2010). From IL-15 to IL-33: the never-ending list of new players in inflammation. Is it time to forget the humble aspirin and move ahead? Biochem. Pharmacol. 79, 525–534. 10.1016/j.bcp.2009.09.015 - DOI - PubMed
1. de Boer O. J., Li X., Teeling P., Mackaay C., Ploegmakers H. J., van der Loos C. M., et al. . (2013). Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb. Haemost. 109, 290–297. 10.1160/TH12-06-0425 - DOI - PubMed
1. Hot A., Lavocat F., Lenief V., Miossec P. (2013). Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-α on endothelial cells. Ann. Rheum. Dis. 72, 754–760. 10.1136/annrheumdis-2012-201887 - DOI - PubMed